At a glance
ClinicalIndex Comparison RecordN/ACompleted· 72 enrolled
Drug / intervention
Enlite 1 connected to iPro2 recorderdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pivotal Study to Evaluate Enlite™ Sensor Performance With iPro™2 in China
In Brief
A clinical study evaluating Enlite 1 connected to iPro2 recorder for Diabetes Mellitus. Completed, enrolled 72 participants across 3 sites.
Detailed Summary
The purpose of this study is to demonstrate the performance and safety of the Enlite Sensor over 144 hours (6 days) when inserted in the abdomen and used with the iPro2 in subjects age 14 - 75 years.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 2018
Enrollment StartJun 2018
Primary CompletionSep 2018
TodayJul 2026
First PostedJan 31, 2018
Enrollment StartJun 28, 2018
Primary CompletionSep 20, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 8.4 years ago
Interventions
Enlite 1 connected to iPro2 recorderdevice
Use Enlite Sensor over 144 hours (6 days) when inserted in the abdomen and used with the iPro2 in subjects age 14 - 75 years.